期刊文献+

中耳胆脂瘤发病机制研究进展 被引量:16

Advance research on the pathogenesis of middle ear cholesteatoma
原文传递
导出
摘要 中耳胆脂瘤是颞骨内异常生长的角质化鳞状上皮对周围骨质渐进性破坏的一种良性病变,其特点是上皮细胞强烈的增殖后,角蛋白碎片大量沉积且经一系列复杂的生理生化反应对周围组织进行破坏和侵蚀,从而造成多种颅内外并发症,如听力下降、前庭功能障碍、面神经损害、脑脓肿等。其在耳鼻咽喉科属常见病、多发病。 Summary Cholesteatoma is a non-neoplastic, keratinizing lesion, characterized by the proliferation of epithe- lium with aberrant micro-architecture into the middle ear or mastoid cavity. The exact pathogenic molecular mech- anisms behind the formation and propagation of cholesteatoma remain unclear. Without timely detection and inter- vention, cholesteatomas can become dangerous and result in numerous intracranial and extracranial complications. In this review, the current researches about inflammatory mediators, enzymatic activity, growth factors, oxidative stress,infection and genetics in acquired cholesteatoma pathogenesis are discussed.
作者 李强 江红群
出处 《临床耳鼻咽喉头颈外科杂志》 CAS 北大核心 2016年第4期338-341,共4页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
关键词 胆脂瘤 中耳 发病机制 分子生物学 cholesteatoma, middle ear pathogenesis molecular biology
  • 相关文献

参考文献26

  • 1DJURHUUS B D, SKYTTHE A, CHRISTENSEN K, et al. Cholesteatoma in Danish children-A national study of changes in the incidence rate over 34 years[J]. Int J Pediatr Otorhinolaryngol, 2015,79 : 127-- 130.
  • 2DORNELLES C, MEURER L, SELAIMEN DA COSTA S, et al. Histologic description of acquired eholesteatomas: comparison between children and a- dults[J]. Braz J Otorhinolaryngol, 2006, 72:641 -- 648.
  • 3KUO C L. Etiopathogenesis of acquired cholesteato- ma:prominent theories and recent advances in biomo- lecular research[J] . Laryngoscope, 2015,125 : 234-- 240.
  • 4JACKLER R K, SANTA MARIA P L, VARSAK Y K, et al. A new theory on the pathogenesis of acquired cholesteatoma: Mucosal traction[J]. Laryngoscope, 2015,125 Suppl 4:S1--S14.
  • 5LOUW L. Acquired cholesteatoma: summary of the cascade of molecular events[J]. J Laryngol Otol, 2013,127..542--549.
  • 6SZCZEPANSKI M J, LUCZAK M, OLSZEWSKA E,et al. Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis [J]. J Mol Med (Berl), 2015,93305--314.
  • 7CHI Z, WANG Z, LIANG Q, et al. Induction of cy- tokine production in cholesteatoma keratinocytes by extracellular high-mobility group box chromosomal protein 1 combined with DNA released by apoptotic cholesteatoma keratinocytes [J]. Mol Cell Biochem, 2015,400(I-- 2) : 189--200.
  • 8VISSE R, NAGASE H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry[J]. Circ Res, 2003,92: 827--839.
  • 9JUH,SZ A, SZIKLAI I, R.KOSY Z, et aL Elevat- ed level of tenascin and matrix metalloproteinase 9correlates with the bone destruction capacity of chol- esteatomas[J]. Oto] Neuroto], 2009,30 : 559-- 565.
  • 10REZENDE C E, SOUTO R P, RAPOPORT P B,et al. Cholesteatoma gene expression of matrixmetallo- proteinases and their inhibitors by RT-PCR[J]. Braz J Otorhinolaryngol, 2012,78 : 116-- 121.

同被引文献99

引证文献16

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部